BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21846799)

  • 1. GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis.
    Shohreh R; Pardo CA; Guaraldi F; Schally AV; Salvatori R
    Endocrinology; 2011 Oct; 152(10):3803-10. PubMed ID: 21846799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial reversibility of growth hormone (GH) deficiency in the GH-releasing hormone (GHRH) knockout mouse by postnatal treatment with a GHRH analog.
    Alba M; Schally AV; Salvatori R
    Endocrinology; 2005 Mar; 146(3):1506-13. PubMed ID: 15564325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: Requirement for growth hormone-releasing hormone in the development of experimental autoimmune encephalomyelitis.
    Ikushima H; Kanaoka M; Kojima S
    J Immunol; 2003 Sep; 171(6):2769-72. PubMed ID: 12960295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.
    Alba M; Fintini D; Sagazio A; Lawrence B; Castaigne JP; Frohman LA; Salvatori R
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1290-4. PubMed ID: 16822960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined long-term treatment with a growth hormone-releasing hormone analogue and a growth hormone secretagogue in the growth hormone-releasing hormone knock out mouse.
    Fintini D; Alba M; Schally AV; Bowers CY; Parlow AF; Salvatori R
    Neuroendocrinology; 2005; 82(3-4):198-207. PubMed ID: 16601359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice.
    Alba M; Fintini D; Salvatori R
    Growth Horm IGF Res; 2005 Aug; 15(4):275-82. PubMed ID: 15979916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL/J mice.
    Stevens DB; Chen K; Seitz RS; Sercarz EE; Bronstein JM
    J Immunol; 1999 Jun; 162(12):7501-9. PubMed ID: 10358205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.
    Kihara Y; Ishii S; Kita Y; Toda A; Shimada A; Shimizu T
    J Exp Med; 2005 Sep; 202(6):853-63. PubMed ID: 16172262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
    Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
    J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
    Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
    J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell-independent modulation of experimental autoimmune encephalomyelitis in ADAP-deficient mice.
    Engelmann S; Togni M; Thielitz A; Reichardt P; Kliche S; Reinhold D; Schraven B; Reinhold A
    J Immunol; 2013 Nov; 191(10):4950-9. PubMed ID: 24101551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice.
    Sagazio A; Xiao X; Wang Z; Martari M; Salvatori R
    J Endocrinol; 2008 Jan; 196(1):79-88. PubMed ID: 18180319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.